HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qingda granule attenuates angiotensin II-induced cardiac hypertrophy and apoptosis and modulates the PI3K/AKT pathway.

Abstract
Qingda granule (QDG), simplified from Qingxuan Jiangya Decoction, is a well-known traditional Chinese medicine formula that has been used for decades to treat hypertension. However, the cardioprotective effects of QDG on Ang II-induced hypertension remain unknown. This study aimed to investigate the effects of QDG on hypertension-induced cardiac hypertrophy and apoptosis, as well as explore its underlying mechanisms. Mice were infused with Ang II (500 ng/kg/min) or saline solution as control, then administered oral QDG (1.145 g/kg/day) or saline for two weeks. QDG treatment attenuated the elevation in blood pressure caused by Ang II, as well as the decreased left ventricle ejection fractions and fractional shortening. Moreover, QDG treatment significantly alleviated the Ang II-induced elevation of the ratio of heart weight to tibia length, as well as cardiac injury, hypertrophy, and apoptosis. In cultured H9C2 cells stimulated with Ang II, QDG partially reversed the increase in cell surface area and number of apoptotic cells, up-regulation of hypertrophy markers ANP and BNP, and activation of caspases-9 and -3. QDG also partially reversed Ang II-induced accumulation of reactive oxygen species (ROS), depolarization of the mitochondrial membrane, release of cytochrome C, up-regulation of Bax, and decrease in levels of p-PI3K, p-AKT, and Bcl-2. These results suggest that QDG can significantly attenuate Ang II-induced hypertension, cardiac hypertrophy and apoptosis, and it may exert these effects in part by suppressing ROS production and activating the PI3K/AKT signaling pathway.
AuthorsYing Cheng, Aling Shen, Xiangyan Wu, Zhiqing Shen, Xiaoping Chen, Jiapeng Li, Liya Liu, Xiaoying Lin, Meizhu Wu, Youqin Chen, Jianfeng Chu, Jun Peng
JournalBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother) Vol. 133 Pg. 111022 (Jan 2021) ISSN: 1950-6007 [Electronic] France
PMID33378940 (Publication Type: Journal Article)
CopyrightCopyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Chemical References
  • Drugs, Chinese Herbal
  • Reactive Oxygen Species
  • qingda granules
  • Angiotensin II
  • Phosphatidylinositol 3-Kinase
  • Proto-Oncogene Proteins c-akt
Topics
  • Angiotensin II
  • Animals
  • Apoptosis (drug effects)
  • Blood Pressure (drug effects)
  • Cell Line
  • Disease Models, Animal
  • Drugs, Chinese Herbal (pharmacology)
  • Gene Expression Regulation
  • Gene Regulatory Networks
  • Hypertension (chemically induced, enzymology, physiopathology, prevention & control)
  • Hypertrophy, Left Ventricular (chemically induced, enzymology, pathology, prevention & control)
  • Male
  • Mice, Inbred C57BL
  • Myocytes, Cardiac (drug effects, enzymology, pathology)
  • Phosphatidylinositol 3-Kinase (metabolism)
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Rats
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: